William Blair Issues Pessimistic Estimate for USPH Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Investment analysts at William Blair reduced their Q3 2025 earnings estimates for shares of U.S. Physical Therapy in a research report issued to clients and investors on Tuesday, May 13th. William Blair analyst J. Haase now expects that the company will post earnings of $0.70 per share for the quarter, down from their prior estimate of $0.77. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q4 2025 earnings at $0.72 EPS and FY2025 earnings at $2.61 EPS.

A number of other equities research analysts also recently issued reports on USPH. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. JMP Securities reissued a “market outperform” rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. dropped their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, March 19th. Finally, Barrington Research dropped their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average price target of $109.00.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock opened at $79.90 on Thursday. The company’s 50 day simple moving average is $71.85 and its 200-day simple moving average is $83.54. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of 84.99, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy has a 1 year low of $62.77 and a 1 year high of $107.09. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business’s revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.51 EPS.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors and hedge funds have recently modified their holdings of the company. CBIZ Investment Advisory Services LLC grew its stake in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after purchasing an additional 122 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock worth $32,000 after purchasing an additional 400 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of U.S. Physical Therapy during the fourth quarter worth $39,000. Venturi Wealth Management LLC grew its stake in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after purchasing an additional 704 shares in the last quarter. Finally, Fifth Third Bancorp grew its stake in shares of U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock worth $75,000 after purchasing an additional 265 shares in the last quarter.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be paid a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.25%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 82.57%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.